| Literature DB >> 35739898 |
Diego Manriquez1, Guilhem Poudevigne1, Etienne Roche1, Agnes Waret-Szkuta1.
Abstract
The objective of this study is to evaluate the association between the head-to-chest circumference ratio (HCR) and birth weight (BW), colostrum intake, and average daily weight gain (ADG) at preweaning and postweaning periods. Additionally, associations between HCR and PCV-2 serum antibody titers and the PCV-2 seroconversion ratio (SCR) were assessed. Head and chest circumferences were measured at birth, and HCR was calculated from 110 piglets born from 8 pregnant sows randomly selected from maternity pens. Linear mixed models were used to test whether changes in HCR were associated with fluctuations of BW, colostrum intake, and ADG. In addition, HCR least-square means were compared between piglets classified as lower or greater BW, colostrum intake, and ADG. Finally, receiving operating characteristic curve analyses were performed to estimate HCR thresholds for discriminating between lower and greater performance piglets during preweaning and postweaning periods. Increments in HCR were associated with lower BW, colostrum intake, and ADG. An HCR threshold of 0.82 maximized sensibility and specificity for the classification of lower and greater performance piglets regarding BW, colostrum intake, and ADG during the periods of 0 to 7 and 0 to 69 days of life. When piglets were categorized into HCR ≤ 0.82 and HCR > 0.82 groups, piglets with HCR ≤ 0.82 had lower (log10) PCV-2 serum antibody titers at 26 days of life compared with piglets with HCR > 0.82 (3.30 ± 0.05 vs. 3.47 ± 0.05 g/dL). On the other hand, piglets that showed low SCR between 26 and 69 days of life had greater HCRs compared with piglets with high SCRs (0.83 ± 0.008 vs. 0.8 ± 0.008). The use of HCRs allowed us to identify piglets with lower performance and impaired immune response against PCV-2. The HCR indicator could be used as a selection criterion for preventive management for piglets showing delayed performance potentially associated with IUGR.Entities:
Keywords: PCV-2; growth; immaturity; sow prolificacy
Year: 2022 PMID: 35739898 PMCID: PMC9219466 DOI: 10.3390/ani12121562
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Figure 1Timeline of the study procedures performed during preweaning and postweaning periods. Blood samples for determination of serum IgG 1 and PCV-2 2 antibodies titer. h: hours of life; d: days of life. 3 Vaccination against PCV-2. Clinical inspection was performed daily throughout the study period.
Figure 2Measuring points of head circumference (HC) and chest circumference (CC) from newborn piglets. Photo copyright by Guy-Pierre Martineau.
Mean and standard deviation (SD) of the study outcome variables measured in piglets followed from birth until 69 days of life.
| Outcome Variables | Mean | SD |
|---|---|---|
| Birth weight (g) | 1451.6 | 274.9 |
| Colostrum intake (g) | 357.6 | 101.9 |
| Average daily gain (g/day) | ||
| 0–69 d | 374.0 | 71.6 |
| 0–7 d | 196.7 | 54.6 |
| 7–21 d | 261.5 | 57.5 |
| 21–47 d | 282.1 | 87.3 |
| 47–69 d | 549.6 | 126.0 |
| PCV-2 antibody titers (log10) | ||
| 26 d | 3.4 | 0.4 |
| 47 d | 3.3 | 0.3 |
| 69 d | 3.7 | 0.3 |
| PCV-2 SCR 1 | ||
| 47–26 d | 1.0 | 0.1 |
| 69–26 d | 1.1 | 0.2 |
| 69–47 d | 1.1 | 0.2 |
1 PCV-2, seroconversion ratio (SCR) between sampling points. SD, standard deviation.
Figure 3Proportion of study piglets (n = 110) classified in the covariates measured during the preweaning and postweaning periods. BVS1: breathed and not moved during the first 15 s of life; BVS-2: breathed and moved within 15 s of life; BVS-3: breathed, moved, and tried to stand up during the first seconds of life. Birth time (h) relative to the first piglet born. Cross-fostering (h) after birth.
Adjusted HCR linear regression estimates associated with study outcomes.
| Study Outcomes | Estimate | SE | Adj. R-Squared | |
|---|---|---|---|---|
| Birth weight (g) | ||||
| Intercept | 4114.3 | 429.3 | <0.0001 | 0.34 |
| HCR | −3314.6 | 521.7 | <0.0001 | |
| Colostrum intake (g) | 0.39 | |||
| Intercept | 870.1 | 189.6 | <0.0001 | |
| HCR | −687.2 | 220.9 | 0.0002 | |
| Average daily gain (g/day) | 0.46 | |||
| 0 to 7 days | ||||
| Intercept | 444.9 | 87.9 | <0.0001 | |
| HCR | −292.8 | 102.2 | 0.005 | |
| 7 to 21 days | 0.34 | |||
| Intercept | 445.2 | 119.1 | 0.005 | |
| HCR | −204.4 | 138.2 | 0.005 | |
| 21 to 47 days | ||||
| Intercept | 498.9 | 156.5 | 0.002 | |
| HCR | −311.1 | 183.8 | 0.09 | |
| 47 to 69 days | 0.32 | |||
| Intercept | 566.1 | 267.5 | 0.03 | |
| HCR | −26.3 | 315.4 | 0.9 | |
| 0 to 69 days | 0.46 | |||
| Intercept | 539.3 | 133.4 | 0.0001 | |
| HCR | −232.9 | 155.1 | 0.0001 | |